Literature DB >> 2515236

Ovarian hyperstimulation associated with the sole use of leuprolide for ovarian suppression.

J Yeh1, R L Barbieri, V A Ravnikar.   

Abstract

An IVF patient who was placed on leuprolide therapy prior to ovulation induction to improve ovarian response developed moderate ovarian hyperstimulation from the sole use of the GnRH agonist. Clinicians should be aware of this possible outcome.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2515236     DOI： 10.1007/bf01132875

Source DB:  PubMed          Journal:  J In Vitro Fert Embryo Transf        ISSN： 0740-7769


  7 in total

1.  An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

Authors:  P Serafini; B Stone; J Kerin; J Batzofin; P Quinn; R P Marrs
Journal:  Fertil Steril       Date:  1988-01       Impact factor: 7.329

2.  Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment.

Authors:  E Radwanska; R G Rawlins; I Tummon; V Maclin; Z Binor; W P Dmowski
Journal:  Fertil Steril       Date:  1988-02       Impact factor: 7.329

3.  Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women.

Authors:  D R Meldrum; Z Tsao; S E Monroe; G D Braunstein; J Sladek; J K Lu; W Vale; J Rivier; H L Judd; R J Chang
Journal:  J Clin Endocrinol Metab       Date:  1984-04       Impact factor: 5.958

4.  Suppression of the ovary using a gonadotropin releasing-hormone agonist prior to stimulation for oocyte retrieval.

Authors:  D de Ziegler; M I Cedars; D Randle; J K Lu; H L Judd; D R Meldrum
Journal:  Fertil Steril       Date:  1987-11       Impact factor: 7.329

5.  Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization.

Authors:  S Neveu; B Hedon; J Bringer; J M Chinchole; F Arnal; C Humeau; P Cristol; J L Viala
Journal:  Fertil Steril       Date:  1987-04       Impact factor: 7.329

6.  Acute ovarian responses to a long-acting agonist of gonadotropin-releasing hormone in ovulatory women and women with polycystic ovarian disease.

Authors:  J DeFazio; D R Meldrum; J K Lu; W W Vale; J E Rivier; H L Judd; R J Chang
Journal:  Fertil Steril       Date:  1985-10       Impact factor: 7.329

7.  Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles.

Authors:  R Palermo; G Amodeo; D Navot; Z Rosenwaks; E Cittadini
Journal:  Fertil Steril       Date:  1988-02       Impact factor: 7.329
  7 in total
  2 in total

1.  Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilisation treatment.

Authors:  S Brett; P Y Yong; K J Thong
Journal:  J Assist Reprod Genet       Date:  2001-06       Impact factor: 3.412

2.  Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients.

Authors:  Jacob Christ; Christopher N Herndon; Bo Yu
Journal:  J Assist Reprod Genet       Date:  2021-01-20       Impact factor: 3.412
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.